Ghanshyam Goyal

Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

W. Timothy Garvey, Juan P. Frías, Ania M. Jastreboff et al. · The Lancet · 2023 · 590 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +6

MGB-OAGB: Effect of Biliopancreatic Limb Length on Nutritional Deficiency, Weight Loss, and Comorbidity Resolution

Anmol Ahuja, Om Tantia, Ghanshyam Goyal et al. · Obesity Surgery · 2018 · 148 citations

Obesity, Metabolic Syndrome, Nutrition +12

LSG vs OAGB—1 Year Follow-up Data—a Randomized Control Trial

Shivakumar Seetharamaiah, Om Tantia, Ghanshyam Goyal et al. · Obesity Surgery · 2016 · 105 citations

Marginal Structural Models, Clinical Trials, Randomized Controlled Trial

LSG vs MGB-OAGB—3 Year Follow-up Data: a Randomised Control Trial

S. Shivakumar, Om Tantia, Ghanshyam Goyal et al. · Obesity Surgery · 2018 · 61 citations

Clinical Effectiveness, Clinical Trials, Outcomes Research +5

LSG vs MGB-OAGB: 5-Year Follow-up Data and Comparative Outcome of the Two Procedures over Long Term—Results of a Randomised Control Trial

Mayank Jain, Om Tantia, Ghanshyam Goyal et al. · Obesity Surgery · 2020 · 51 citations

Lsg Vs Mgb-oagb, Meta-analysis, Clinical Effectiveness +7